Song, Joo Y. http://orcid.org/0000-0003-3497-2513
Dirnhofer, Stefan
Piris, Miguel A.
Quintanilla-Martínez, Leticia
Pileri, Stefano
Campo, Elias
Article History
Received: 9 September 2022
Revised: 22 November 2022
Accepted: 23 November 2022
First Online: 2 December 2022
Declarations
:
: Compliance with all ethical standards was undertaken for this work. No research involving human or animals was performed. No informed consent was required.
: JYS, SD, LQM, SP do not have any conflicts to disclose. MAP has the following disclosures: Millenium/Takeda: Advisory Board, Lecture Fees, Research Funding; Celgene: Advisory Board; Gilead: Advisory Board; Research funding; Jansen: Advisory Board; Lecture Fees; Nanostring: Advisory Board; Kyowa Kirin: Advisory Board; Kura: Research Funding. EC has been a consultant for Takeda, NanoString, and Illumina; has received honoraria from Janssen, EUSPharma, Takeda and Roche for speaking at educational activities; and is an inventor on a Lymphoma and Leukemia Molecular Profiling Project patent “Method for subtyping lymphoma subtypes by means of expression profiling” (PCT/US2014/64161) and on a bioinformatic pipeline “IgCaller” not related to this project.